{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:34:57Z","timestamp":1761708897783},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T00:00:00Z","timestamp":1381363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosgenetics.org"],"crossmark-restriction":false},"short-container-title":["PLoS Genet"],"DOI":"10.1371\/journal.pgen.1003765","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T16:13:06Z","timestamp":1381507986000},"page":"e1003765","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pgen.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Cooperation between RUNX1-ETO9a and Novel Transcriptional Partner KLF6 in Upregulation of Alox5 in Acute Myeloid Leukemia"],"prefix":"10.1371","volume":"9","author":[{"given":"Russell C.","family":"DeKelver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentson","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Komeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandler","family":"Rundle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao-Chia","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Er","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"key":"ref1","unstructured":"National Cancer Institute (2013) Adult Acute Myeloid Leukemia Treatment. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cancer.gov\/cancertopics\/pdq\/treatment\/adultAML\" xlink:type=\"simple\">http:\/\/www.cancer.gov\/cancertopics\/pdq\/treatment\/adultAML<\/ext-link> Accessed April 3, 2013."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.1365-2141.2000.02474.x","article-title":"Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia","volume":"111","author":"D Rowe","year":"2000","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-4608(90)90043-A","article-title":"Acute myelogenous leukemia with an 8;21 translocation. A report on 148 cases from the Groupe Francais de Cytogenetique Hematologique","volume":"44","year":"1990","journal-title":"Cancer Genet Cytogenet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V86.1.1.bloodjournal8611","article-title":"AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia","volume":"86","author":"G Nucifora","year":"1995","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1365-2141.1997.4663270.x","article-title":"Incidence of AML1\/ETO fusion transcripts in patients entered into the MRC AML trials. MRC Adult Leukaemia Working Party","volume":"99","author":"SE Langabeer","year":"1997","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10428190009054882","article-title":"Disease features in acute myeloid leukemia with t(8;21)(q22;q22). Influence of age, secondary karyotype abnormalities, CD19 status, and extramedullary leukemia on survival","volume":"40","author":"K Rege","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1182\/blood-2006-11-019265","article-title":"Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts","volume":"110","author":"LF Peterson","year":"2007","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1038\/onc.2008.196","article-title":"Complementing mutations in core binding factor leukemias: from mouse models to clinical applications","volume":"27","author":"AM Muller","year":"2008","journal-title":"Oncogene"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1182\/blood-2003-05-1762","article-title":"Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element","volume":"102","author":"JC Mulloy","year":"2003","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nm1443","article-title":"A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis","volume":"12","author":"M Yan","year":"2006","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/gcc.20165","article-title":"MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21)","volume":"43","author":"T Kozu","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1128\/MCB.18.12.7185","article-title":"Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO","volume":"18","author":"V Gelmetti","year":"1998","journal-title":"Mol Cell Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1128\/MCB.18.12.7176","article-title":"ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors","volume":"18","author":"B Lutterbach","year":"1998","journal-title":"Mol Cell Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1073\/pnas.95.18.10860","article-title":"ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR\/mSin3\/HDAC1 complex","volume":"95","author":"J Wang","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bcmd.2007.05.005","article-title":"Cell type dependent regulation of multidrug resistance-1 gene expression by AML1-ETO","volume":"39","author":"R Hines","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/leu.2012.49","article-title":"Depletion of RUNX1\/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding","volume":"26","author":"A Ptasinska","year":"2012","journal-title":"Leukemia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1182\/blood-2012-05-429050","article-title":"ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia","volume":"120","author":"JH Martens","year":"2012","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2011-12-395335","article-title":"Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML","volume":"120","author":"MC Lo","year":"2012","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.1201662","article-title":"The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation","volume":"333","author":"L Wang","year":"2011","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1182\/blood-2011-04-347476","article-title":"PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential","volume":"119","author":"WJ Shia","year":"2012","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bbrc.2005.07.166","article-title":"LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways","volume":"335","author":"WG Tong","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/onc.2009.412","article-title":"Ras-induced invasion and metastasis are regulated by a leukotriene B4 receptor BLT2-linked pathway","volume":"29","author":"EY Kim","year":"2010","journal-title":"Oncogene"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/ATVBAHA.109.185793","article-title":"Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis","volume":"29","author":"GY Kim","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1074\/jbc.M509999200","article-title":"The inflammatory mediator leukotriene D4 induces beta-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells","volume":"281","author":"M Mezhybovska","year":"2006","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/carcin\/19.8.1393","article-title":"Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents","volume":"19","author":"N Rioux","year":"1998","journal-title":"Carcinogenesis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1593\/neo.04559","article-title":"LY293111 improves efficacy of gemcitabine therapy on pancreatic cancer in a fluorescent orthotopic model in athymic mice","volume":"7","author":"R Hennig","year":"2005","journal-title":"Neoplasia"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10555-007-9098-3","article-title":"Lipoxygenase metabolism: roles in tumor progression and survival","volume":"26","author":"GP Pidgeon","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/emm.2005.6","article-title":"Leukotriene B4 pathway regulates the fate of the hematopoietic stem cells","volume":"37","author":"JW Chung","year":"2005","journal-title":"Exp Mol Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.389","article-title":"Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia","volume":"41","author":"Y Chen","year":"2009","journal-title":"Nat Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood.V58.6.1203.1203","article-title":"Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B","volume":"58","author":"KR Rai","year":"1981","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/CCO.0b013e328358f62d","article-title":"Current treatment of acute myeloid leukemia","volume":"24","author":"GJ Roboz","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials","volume":"116","author":"D Grimwade","year":"2010","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2005-05-1916","article-title":"Developmental regulation of yolk sac hematopoiesis by Kruppel-like factor 6","volume":"107","author":"N Matsumoto","year":"2006","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia","volume":"350","author":"PJ Valk","year":"2004","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1165\/ajrcmb.26.4.4747","article-title":"Cloning and functional analysis of the mouse 5-lipoxygenase promoter","volume":"26","author":"ES Silverman","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ydbio.2009.08.009","article-title":"Regulation of gene expression via the core promoter and the basal transcriptional machinery","volume":"339","author":"T Juven-Gershon","year":"2010","journal-title":"Dev Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1074\/jbc.275.12.8903","article-title":"Cell-specific transcription of leukotriene C(4) synthase involves a Kruppel-like transcription factor and Sp1","volume":"275","author":"JL Zhao","year":"2000","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1182\/blood-2010-05-285353","article-title":"Role of Kruppel-like factors in leukocyte development, function, and disease","volume":"116","author":"Z Cao","year":"2010","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1182\/blood.V100.12.4001","article-title":"Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury","volume":"100","author":"LM Botella","year":"2002","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.febslet.2008.05.030","article-title":"AML1-ETO interacts with Sp1 and antagonizes Sp1 transactivity through RUNT domain","volume":"582","author":"H Wei","year":"2008","journal-title":"FEBS Lett"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccr.2007.04.010","article-title":"Structural basis for recognition of SMRT\/N-CoR by the MYND domain and its contribution to AML1\/ETO&apos;s activity","volume":"11","author":"Y Liu","year":"2007","journal-title":"Cancer Cell"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1182\/blood-2012-11-465641","article-title":"Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential","volume":"121","author":"RC Dekelver","year":"2013","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.leu.2401014","article-title":"Hematological malignancies with t(9;11)(p21-22;q23)\u2013a laboratory and clinical study of 125 cases. European 11q23 Workshop participants","volume":"12","author":"GJ Swansbury","year":"1998","journal-title":"Leukemia"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1182\/blood.V83.1.10.10","article-title":"Acute promyelocytic leukemia: from genetics to treatment","volume":"83","author":"F Grignani","year":"1994","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ccr.2005.12.014","article-title":"Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia","volume":"9","author":"YH Kuo","year":"2006","journal-title":"Cancer Cell"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1128\/MCB.22.15.5506-5517.2002","article-title":"Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation","volume":"22","author":"CG de Guzman","year":"2002","journal-title":"Mol Cell Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1158\/0008-5472.CAN-12-0255","article-title":"STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2","volume":"73","author":"WF Tam","year":"2013","journal-title":"Cancer Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e38614","DOI":"10.1371\/journal.pone.0038614","article-title":"LSK derived LSK- cells have a high apoptotic rate related to survival regulation of hematopoietic and leukemic stem cells","volume":"7","author":"C Peng","year":"2012","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.stem.2012.02.007","article-title":"Hematopoietic stem cell subtypes expand differentially during development and display distinct lymphopoietic programs","volume":"10","author":"C Benz","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1038\/sj.onc.1207727","article-title":"The 8;21 translocation in leukemogenesis","volume":"23","author":"LF Peterson","year":"2004","journal-title":"Oncogene"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2011.03.014","article-title":"SON Controls Cell-Cycle Progression by Coordinated Regulation of RNA Splicing","volume":"42","author":"EY Ahn","year":"2011","journal-title":"Mol Cell"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/372179a0","article-title":"Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene","volume":"372","author":"XS Chen","year":"1994","journal-title":"Nature"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1038\/sj.leu.2404849","article-title":"The multi-functional cellular adhesion molecule CD44 is regulated by the 8;21 chromosomal translocation","volume":"21","author":"LF Peterson","year":"2007","journal-title":"Leukemia"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1128\/MCB.13.10.6336","article-title":"Identification of AML-1 and the (8;21) translocation protein (AML-1\/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions","volume":"13","author":"S Meyers","year":"1993","journal-title":"Mol Cell Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1158\/0008-5472.CAN-04-4249","article-title":"A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk","volume":"65","author":"G Narla","year":"2005","journal-title":"Cancer Res"}],"container-title":["PLoS Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pgen.1003765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T18:24:24Z","timestamp":1596651864000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1003765"}},"subtitle":[],"editor":[{"given":"H. Leighton","family":"Grimes","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,10]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgen.1003765","relation":{},"ISSN":["1553-7404"],"issn-type":[{"value":"1553-7404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,10]]}}}